Immunology of anaphylaxis: Lessons from murine models

Current Allergy and Asthma Reports

Volumn 7, Issue 1, 2007, Pages 49-55

  Baeza, M Luisa ^a   Zubeldia, José Manuel ^b  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GROWTH FACTOR; CANCER GROWTH FACTOR BETA; CYTOKINE; FC RECEPTOR; FOOD ALLERGEN; HISTAMINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN E RECEPTOR; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 4; INTERLEUKIN 9; THROMBOCYTE ACTIVATING FACTOR; UNCLASSIFIED DRUG;

ALLERGIC REACTION; ANAPHYLAXIS; B LYMPHOCYTE; BACTERIAL INFECTION; CELLULAR IMMUNITY; DISEASE MODEL; DRUG MECHANISM; EXPERIMENTAL MOUSE; FOOD ALLERGY; GENETIC SUSCEPTIBILITY; HELMINTHIASIS; HUMAN VERSUS ANIMAL COMPARISON; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; IMMUNOPATHOLOGY; IMMUNOREGULATION; MAST CELL; NONHUMAN; PARASITOSIS; PEANUT; REVIEW; SPECIES DIFFERENCE; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ANAPHYLAXIS; ANIMALS; DISEASE MODELS, ANIMAL; FOOD HYPERSENSITIVITY; HUMANS; MICE; PARASITIC DISEASES;

EID: 34247518597     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-007-0030-2     Document Type: Review

References (56)

1. Sampson HA, Muñtoz-Furlong A, Campbell RL, et al.: Second symposium on the definition and management of anaphylaxis: summary report - Second National Institute of Allergy and Infectious Disease/ Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006, 117:391-397.
2. Portier P, Richet C: De l'action anaphylactic de certains veninis. C R Siances Mem Soc Biol Paris 1902, 54:170.
3. Daser A, Batjer N, Kolsch U, et al.: Quantitative assessment of immediate cutaneous hypersensitivity in a model of genetic predisposition to atopy. Int Arch Allergy Immunol 1998, 117:239-243.
4. Fung-Leung WP, De Sousa-Hitzler J, Ishaque A, et al.: Transgenic mice expressing the human high-affinity immunoglobulin (Ig) E receptor alpha chain respond to human IgE in mast cell degranulation and in allergic reactions. J Exp Med 1996, 183:49-56.
5. Gounni AS, Lamkhioued B, Ochiai K, et al.: High-affinity IgE receptor on eosinophils is involved in defence against parasites. Nature 1994, 367:183-186.
6. Ochiai K, Wang B, Rieger A, et al.: A review on Fc epsilon RI on human epidermal Langerhans cells. Int Arch Allergy Immunol 1994, 104(suppl 1):63-64.
7. Wang B, Rieger A, Kilgus O, et al.: Epidermal Langerhans cells from normal human skin bind monomeric IgE via Fc epsilon RI. J Exp Med 1992, 175:1353-1365.
8. Strait RT, Morris SC, Yang M, et al.: Pathways of anaphylaxis in the mouse. J Allergy Clin Immunol 2002, 109:658-668.
9. Finkelman FD, Rothenberg ME, Brandt EB, et al.: Molecular mechanisms of anaphylaxis: lessons from studies with murine models. J Allergy Clin Immunol 2005, 115:449-457, quiz 458.
10. Dombrowicz D, Flamand V, Brigman KK, et al.: Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin E receptor alpha chain gene. Cell 1993, 75:969-976.
11. Kimura S, Nagata M, Takeuchi M, et al.: Anti-granulocyte antibody suppression of active and passive anaphylactic shock in WBB6F1-W/Wv mice. Cell Mol Life Sci 1997, 53:663-666.
12. Strait RT, Morris SC, Smiley K, et al.: IL-4 exacerbates anaphylaxis. J Immunol 2003, 170:3835-3842.
13. Takeishi T, Martin TR, Katona IM, et al.: Differences in the expression of the cardiopulmonary alterations associated with anti-immunoglobulin E-induced or active anaphylaxis in mast cell-deficient and normal mice. Mast cells are not required for the cardiopulmonary changes associated with certain fatal anaphylactic responses. J Clin Invest 1991, 88:598-608.
14. Dombrowicz D, Flamand V, Miyajima I, et al.: Absence of Fc epsilonRI alpha chain results in upregulation of Fc gammaRIII-dependent mast cell degranulation. and anaphylaxis. Evidence of competition between Fc epsilonRI and Fc gammaRIII for limiting amounts of FcR beta and gamma chains. J Clin Invest 1997, 99:915-925.
15. Finkelman FD, Scher I, Mond JJ, et al.: Polyclonal activation of the murine immune system by an antibody to IgD. II. Generation of polyclonal antibody production and cells with surface IgG. J Immunol 1982, 129:638-646.
16. Strait RT, Morris SC, Finkelman FD: IgG-blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen interception and Fc gamma RIIb cross-finking. J Clin Invest 2006, 116:833-841.
17. Faquim-Mauro EL, Jacysyn JF, Macedo MS: Anaphylactic and non-anaphylactic murine IgG1 differ in their ability to bind to mast cells: relevance of proper glycosylation of the molecule. Immunobiology 2003, 207:169-177.
18. Wachholz PA, Nouri-Aria KT, Wilson DR, et al.: Grass pollen immunotherapy for hayfever is associated with increases in local nasal but not peripheral Th1:Th2 cytokine ratios. Immunology 2002, 105:56-62.
19. Fellrath JM, Kettner A, Dufour N, et al.: Allergen-specific T-cell tolerance induction with allergen-derived long synthetic peptides: results of a phase I trial. J Allergy Clin Immunol 2003, 111:854-861.
20. Brandt EB, Strait RT, Hershko D, et al.: Mast cells are required for experimental oral allergen-induced diarrhea. J Clin Invest 2003, 112:1666-1677.
21. Knoops L, Louahed J, Van Snick J, Renauld JC: IL-9 promotes but is not necessary for systemic anaphylaxis. J Immunol 2005, 175:335-341.
22. Petit-Frere C, Dugas B, Braquet P, Mencia-Huerta JM: Interleukin-9 potentiates the interleukin-4-induced IgE and IgG1 release from murine B lymphocytes. Immunology 1993, 79:146-151.
23. Godfraind C, Louahed J, Faulkner H, et al.: Intraepithelial infiltration by mast cells with both connective tissue-type and mucosal-type characteristics in gut, trachea, and kidneys of IL-9 transgenic mice. J Immunol 1998, 160:3989-3996.
24. Okamoto A, Kawamura T, Kanbe K, et al.: Suppression of serum IgE response and systemic anaphylaxis in a food allergy model by orally administered high-dose TGF-beta. Int Immunol 2005, 17:705-712.
25. Strid J, Thomson M, Hourihane J, et al.: A novel model of sensitization and oral tolerance to peanut protein. Immunology 2004, 113:293-303.
26. Helm RM: Food allergy animal models: an overview. Ann N Y Acad Sci 2002, 964:139-150.
27. Matysiak-Budnik T, van Niel G, Megraud F, et al.: Gastric Helicobacter infection inhibits development of oral tolerance to food antigens in mice. Infect Immun 2003, 71:5219-5224.
28. Li XM, Serebrisky D, Lee SY, et al.: A murine model of peanut anaphylaxis: T- and B-cell responses to a major peanut allergen mimic human responses. J Allergy Clin Immunol 2000, 106:150-158.
29. Adel-Patient K, Bernard H, Ah-Leung S, et al.: Peanut- and cow's milk-specific IgE, Th2 cells and local anaphylactic reaction are induced in BALB/c mice orally sensitized with cholera toxin. Allergy 2005, 60:658-664.
30. Li XM, Schofield BH, Huang CK, et al.: A murine model of IgE-mediated cow's milk hypersensitivity. J Allergy Clin Immunol 1999, 103:206-214.
31. Morafo V, Srivastava K, Huang CK, et al.: Genetic susceptibility to food allergy is linked to differential TH2-TH1 responses in C3H/HeJ and BALB/c mice. J Allergy Clin Immunol 2003, 111:1122-1128.
32. Chen Y, Inobe J, Marks R, et al.: Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 1995, 376:177-180.
33. Smith KM, Eaton AD, Finlayson LM, Garside P: Oral tolerance. Am J Respir Crit Care Med 2000, 162: S175-178.
34. Srivastava KD, Kattan JD, Zou ZM, et al.: The Chinese herbal medicine formula FAHF-2 completely blocks anaphylactic reactions in a murine model of peanut allergy. J Allergy Clin Immunol 2005, 115:171-178.
35. Frossard CP, Hauser C, Eigenmann PA: Antigen-specific secretory IgA antibodies in the gut are decreased in a mouse model of food allergy. J Allergy Clin Immunol 2004, 114:377-382.
36. Yang KD, Liu CA, Chang JC, et al.: Polymorphism of the immune-braking gene CTLA-4 (+49) involved in gender discrepancy of serum total IgE levels and allergic diseases. Clin Exp Allergy 2004, 34:32-37.
37. van Wijk F, Hoeks S, Nierkens S, et al.: CTLA-4 signaling regulates the intensity of hypersensitivity responses to food antigens, but is not decisive in the induction of sensitization. J Immunol 2005, 174:174-179.
38. Li XM, Srivastava K, Huleatt JW, et al.: Engineered recombinant peanut protein and heat-killed Listeria monocytogenes coadministration protects against peanut-induced anaphylaxis in a murine model. J Immunol 2003, 170:3289-3295.
39. Horner AA, Takabayashi K, Beck L, et al.: Optimized conjugation ratios lead to allergen immunostimulatory oligodeoxynucleotide conjugates with retained immunogenicity and minimal anaphylactogenicity. J Allergy Clin Immunol 2002, 110:413-420.
40. Horner AA, Nguyen MD, Ronaghy A, et al.: DNA-based vaccination reduces the risk of lethal anaphylactic hypersensitivity in mice. J Allergy Clin Immunol 2000, 106:349-356.
41. Frossard CP, Hauser C, Eigenmann PA: Oral carrageenan induces antigen-dependent oral tolerance: prevention of' anaphylaxis and induction of lymphocyte anergy in a marine model of food allergy. Pediatr Res 2001, 49:417-422.
42. Yazdanbakhsh M, Kremsner PG, van Ree R: Allergy, parasites, and the hygiene hypothesis. Science 2002, 296:490-494.
43. Umetsu DT, McIntire JJ, Akbari O, et al.: Asthma: an epidemic of dysregulated immunity. Nat Immunol 2002, 3:715-720.
44. Wills-Karp M, Santeliz J, Karp CL: The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat Rev Immunol 2001, 1:69-75.
45. Bashir ME, Andersen P, Fuss IJ, et al.: An enteric helminth infection protects against an allergic response to dietary antigen. J Immunol 2002, 169:3284-3292.
46. Bellinghausen I, Brand U, Steinbrink K, et al.: Inhibition of human allergic T-cell responses by IL-10-treated dendritic cells: differences from hydrocortisone-treated dendritic cells. J Allergy Clin Immunol 2001, 108:242-249.
47. Royer B, Varadaradjalou S, Saas P, et al.: Inhibition of IgE-induced activation of human mast cells by IL-10. Clin Exp Allergy 2001, 31:694-704.
48. Mangan NE, Fallon RE, Smith P, et al.: Helminth infection protects mice from anaphylaxis via EL-10-producing B cells. J Immunol 2004, 173:6346-6356.
49. Pires RR, Oshiro TM, Itami DM, et al.: Production and characterization of a monoclonal antibody against an Ascaris suum allergenic component. Braz J Med Biol Res 2001, 34:1033-1036.
50. Oshiro TM, Rafael A, Enobe CS, et al.: Comparison of different monoclonal antibodies against immuno-suppressive proteins of Ascaris suum. Braz J Med Biol Res 2004, 37:223-226.
51. Oshiro TM, Macedo MS, Macedo-Soares MF: Anti-inflammatory activity of PAS-1, a protein component of Ascaris suum. Inflamm Res 2005, 54:17-21.
52. Gracia-Bara MT, Matheu V, Zubeldia JM, et al.: Anisakis simplex-sensitized patients: should fish be excluded from their diet? Ann Allergy Asthma Immunol 2001, 86:679-685.
53. Audicana MT, Fernández de Corres L, Muñoz D, et al.: Recurrent anaphylaxis caused by Anisakis simplex parasitizing fish. J Allergy Clin Immunol 1995, 96:558-560.
54. Matheu V, Gracia-Bara MT, Rodríguez V, et al.: Shock anafiláctico secundario a rotura espontánea de quite hidatídico esplénico. Rev Esp Alergol Inmunol Clin 1997, 12:242-247.
55. Baeza ML, Coneiero L, Higaki Y, et al.: Anisakis simplex allergy: a murine model of anaphylaxis induced by parasitic proteins displays a mixed Th1/Th2 pattern. Clin Exp Immunol 2005, 142:433-440.
56. Romagnani S: Immunologic influences on allergy and the TH1/TH2 balance. J Allergy Clin Immunol 2004, 113:395-400.